「Noradrenaline」の共起表現一覧(1語右で並び替え)

Noradrenaline

1語右で並び替え

該当件数:37件

  • Monoamines transported by VMATs are mainly noradrenaline, adrenaline and isoprenaline.
  • her of the main two PNS transmitters, i.e. noradrenaline and acetylcholine.
  • ction of BDNF and AMPA-mediated release of noradrenaline and acetylcholine in the hippocampus and f
  • HT)), melatonin, dopamine, norepinephrine ( noradrenaline), and epinephrine (adrenaline), and nitric
  • lso increases release of acetylcholine and noradrenaline, and improves memory retention in animal s
  • pha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.
  • Catecholamines like norepinephrine ( noradrenaline) and epinephrine (adrenaline) signal throu
  • the catecholamine hormones norepinephrine ( noradrenaline), and epinephrine(adrenaline).
  • brown adipose tissue and the secretion of noradrenaline and adrenaline.
  • the reuptake of serotonin, norepinephrine ( noradrenaline) and epinephrine (adrenaline), dopamine, g
  • t does not cause the release of endogenous noradrenaline, as pseudoephedrine does.
  • orbate, and O2, whereas its 3 products are noradrenaline, dehydroascorbate, and H2O.
  • -HT), melatonin, dopamine, norepinephrine ( noradrenaline), epinephrine (adrenaline), and is a cofac
  • vasodilator and it inhibits the release of noradrenaline from sympathetic nerve terminals.
  • th muscles, and it inhibits the release of noradrenaline from sympathetic nerve terminals.
  • ephrine and norepinephrine (adrenaline and noradrenaline) from the adrenal medulla and cortisol fro
  • inephrine (adrenaline) and norepinephrine ( noradrenaline) in particular), on β-adrenergic receptors
  • ate and aspartate, as well as dopamine and noradrenaline in the frontal cortex and hippocampus of r
  • side the terminal it blocks the release of noradrenaline in response to arrival of an action potent
  • to venlafaxine in which the inhibition of noradrenaline is low at low doses and raises as the dose
  • naptic reuptake of dopamine, serotonin and noradrenaline, making it a triple reuptake inhibitor.
  • Noradrenaline neurotransmitter transporter (SLC6A9) IPR0
  • "Effect of noradrenaline on phosphatase activity in synaptic membra
  • ough inhibition of serotonin, dopamine and noradrenaline reuptake is thought to be involved in its
  • -O-desmethyltramadol retains activity as a noradrenaline reuptake inhibitor and so the mix of both
  • often used in conjunction with a selective noradrenaline reuptake inhibitor (such as desipramine) t
  • he newer agent tapentadol also function as noradrenaline reuptake inhibitors, a property that contr
  • cientific research as a standard selective noradrenaline reuptake inhibitor.
  • ,000 and so are selective for dopamine and noradrenaline reuptake, with little or no effect on sero
  • e been found in bone including adrenaline, noradrenaline, serotonin, calcitonin gene-related peptid
  • in antidepressant medications act to raise noradrenaline, such as the SNRIs and the tricyclic antid
  • Noradrenaline therefore remains in the synapse longer, a
  • enal medulla that converts Norepinephrine ( Noradrenaline) to Epinephrine (Adrenaline).
  • other words, these medications prevent the noradrenaline transporter from doing its job.
  • Since the noradrenaline transporter is responsible for most of the
  • is purported to be a serotonin (SERT) and noradrenaline transporter (NET) inhibitor, it also has e
  • somer blocks reuptake of only dopamine and noradrenaline, while the other blocks reuptake of seroto